Head-to-head · free
JPMorgan Chase & Co. vs Marsh & McLennan Companies, Inc.
JPM vs MRSH — return on capital, cash generation, margins and balance sheet side by side.
JPM
2 / 6
measures where JPM leads
MRSH
4 / 6
measures where MRSH leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | JPM · FY2025 | MRSH · FY2025 |
|---|---|---|
| Revenue | $182.4B | $27.0B |
| Net income | $57.0B | $4.2B |
| Revenue growth (yearly, multi-year) | 9.4% | 10.3% |
| Free cash flow | (147.8B) | $5.0B |
| Free cash flow margin | -81.0% | 18.5% |
| Net cash / (debt) | (599.0B) | — |
| ROIC | — | 13.0% |
| Return on equity | 16.8% | 29.3% |
| Gross margin | — | 42.3% |
| Operating margin | — | 23.1% |
| Net debt / EBITDA | — | 2.37x |
Figures are as reported by each company; latest fiscal year shown.
Where JPMorgan Chase & Co.'s cash went (FY2025)
- Capital spending
- $0
- Buybacks
- $34.6B
- Dividends
- $16.6B
- Acquisitions
- $0
- Net debt issued / (repaid)
- $167.0B
Where Marsh & McLennan Companies, Inc.'s cash went (FY2025)
- Capital spending
- $291.0M
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free